Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

More than half of people living with HIV in Kenya have delayed starting treatment because they fear their family members will discover their status. This is according to people living with HIV (PLHIV) ...

Philadelphia Center hosts event with free food and drag performances to raise awareness on HIV Criminalization and its ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure ...

Eleven more drugs were included in the Philippine National Formulary (PNF)’s list of essential medicines, according to the ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...